Cargando…
Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials
BACKGROUND: Clinical trials applying iota-carrageenan nasal spray have previously shown to reduce duration of virus-confirmed common cold. The present study pooled data of two similar clinical trials to provide further evidence for the antiviral effectiveness of carrageenan. METHODS: Individual pati...
Autores principales: | Koenighofer, Martin, Lion, Thomas, Bodenteich, Angelika, Prieschl-Grassauer, Eva, Grassauer, Andreas, Unger, Hermann, Mueller, Christian A, Fazekas, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236476/ https://www.ncbi.nlm.nih.gov/pubmed/25411637 http://dx.doi.org/10.1186/2049-6958-9-57 |
Ejemplares similares
-
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
por: Ludwig, Martin, et al.
Publicado: (2013) -
Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold
por: Eccles, Ron, et al.
Publicado: (2010) -
Non-Clinical Safety Evaluation of Intranasal Iota-Carrageenan
por: Hebar, Alexandra, et al.
Publicado: (2015) -
Iota-Carrageenan is a potent inhibitor of rhinovirus infection
por: Grassauer, Andreas, et al.
Publicado: (2008) -
Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis
por: Graf, Christine, et al.
Publicado: (2018)